Affiliation: The University of North Carolina Chapel Hill, Eshelman School of Pharmacy, Division of Chemical Biology and Medicinal Chemistry

Dr. Katelyn Arnold is an assistant professor at the University of North Carolina Chapel Hill focused on biological applications of glycans generated from chemoenzymatic synthesis. Past work during my doctoral dissertation and the post-doctoral position includes the investigation of synthetic heparin/heparan sulfate oligosaccharides in acute inflammatory and thromboinflammatory disease models. Dr. Arnold’s long-term research goals include developing synthetic oligosaccharide therapeutics for acute and critical care diseases. Recently, Dr. Arnold was recognized by Forbes Magazine on the 2023 “30 Under 30” Science list for her work in glycoscience.